Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents	$ 87,151	$ 189,711
Accounts receivable, net of allowance for credit losses	125,686	110,050
Financing receivables, net of allowance for credit losses	122,618	141,049
Variable consideration receivables, net of allowance for credit losses	43,643	44,218
Inventories	36,378	26,924
Prepaid expenses	13,145	11,802
Film assets, net of accumulated amortization	4,535	4,241
Property, plant and equipment, net of accumulated depreciation	251,518	260,353
Investment in equity securities	1,095	1,087
Other assets	16,294	17,799
Deferred income tax assets, net of valuation allowance	14,369	13,906
Goodwill	61,718	39,027
Other intangible assets, net of accumulated amortization	22,077	23,080
Total assets	800,227	883,247
Liabilities
Accounts payable	22,607	15,943
Accrued and other liabilities	119,138	111,896
Deferred revenue	76,461	81,281
Revolving credit facility borrowings, net of unamortized debt issuance costs	2,660	2,472
Convertible Notes and other borrowings, net	226,527	223,641
Deferred income tax liabilities	14,900	17,642
Total liabilities	462,293	452,875
Commitments and contingencies (see Note 8)
Non-controlling interests
Non-controlling interests	736	758
Shareholders' equity
Capital stock common shares - no par value. Authorized - unlimited number. 55,973,443 issued and outstanding (December 31, 2021 - 58,653,642 issued and outstanding)	388,953	409,979
Other equity	179,571	174,620
Statutory surplus reserve	3,932	3,932
Accumulated deficit	(282,944)	(234,975)
Accumulated other comprehensive (loss) income	(16,173)	2,527
Total shareholders' equity attributable to common shareholders	273,339	356,083
Non-controlling interests	63,859	73,531
Total shareholders' equity	337,198	429,614
Total liabilities and shareholders' equity	$ 800,227	$ 883,247